The FDA has been running a series of podcasts about drug safety for health care professionals. The FDA Drug Safety Podcasts are produced by the FDA’s Center for Drug Evaluation and Research, and provide emerging safety information about drugs in conjunction with the release of Public Health Advisories and other drug safety issues.
The latest one warns about increased risk for serious pancreatitis with the irritable bowel drug eluxadoline (Viberzi, Allergan) in patients without a